Archived Statements and Work Group Reports Share this page: After five years from the date of publication, AAAAI position statements and work group reports are not to be considered to reflect current AAAAI standards or policy. The AAAAI maintains these archives for the purpose of reference only. AAAAI statements are not to be construed as dictating an exclusive course of action; nor are they intended to replace the medical judgment of healthcare professionals. The unique circumstances of individual patients and environments are to be taken into account in any diagnosis and treatment plan. AAAAI statements reflect clinical and scientific advances as of the date of their publication and are subject to change. Allergy: Diagnosis and Treatment Statement name Published Statement type Allergy diagnosis in clinical practice December 2006 Work group report Nasal and sinus endoscopy for medical management of resistant sinusitis, including post-surgical patients November 2006 Work group report Primary prevention of allergic disease through nutritional interventions January 2013 Work group report Use of standardized allergen extracts May 1997 Position statement Allergy / Immunology Workforce Statement name Published Statement type 2012 AI Physician Workforce Report March 2012 Other Allergic Disease Statement name Published Statement type Complementary and Alternative Medicine Use among Allergy Practices: Results of a Nationwide Survey of Allergists January 2018 Work group report Role of the allergist-immunologist and upper airway allergy in sleep-disordered breathing May 2017 Work group report Special Article: COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic March 2020 Special Article Anaphylaxis Statement name Published Statement type Anaphylaxis in schools and other child care settings August 1998 Position statement The Allergist’s Role in Anaphylaxis and Food Allergy Management in the School and Childcare Setting November 2017 Work group report Use of epinephrine in the treatment of anaphylaxis November 2002 Position statement Workgroup Report by the Joint Task Force Involving American Academy of Allergy, Asthma & Immunology (AAAAI); Food Allergy, Anaphylaxis, Dermatology and Drug Allergy (FADDA) (Adverse Reactions to Foods Committee and Adverse Reactions to Drugs, Biologicals, and Latex Committee); and the Centers for Disease Control and Prevention Botulism Clinical Treatment Guidelines Workgroup—Allergic Reactions to Botulinum Antitoxin: A Systematic Review December 2017 Work group report Asthma Statement name Published Statement type A work group report on ultrafine particles (American Academy of Allergy, Asthma & Immunology): Why ambient ultrafine and engineered nanoparticles should receive special attention for possible adverse health outcomes in human subjects August 2016 Work group report Creation and implementation of SAMPRO™: A school-based asthma management program* - The Journal of Allergy and Clinical Immunology (JACI) September 2016 Other Environmental allergen avoidance in allergic asthma February 1999 Position statement Evolving concepts in how viruses impact asthma: A Work Group Report of the Microbes in Allergy Committee of the American Academy of Allergy, Asthma & Immunology May 2020 Work Group Report Exercise induced asthma June 2007 Work group report Fungi and allergic lower respiratory tract diseases February 2012 Work group report Impact of weather and climate change with indoor and outdoor air quality in asthma: A Work Group Report of the AAAAI Environmental Exposure and Respiratory Health Committee May 2019 Work group report Inhaled corticosteroids and systemic infections November 2002 Position statement Medical effects of mold exposure February 2006 Position statement Pest and allergen exposure and abatement in inner city asthma March 2010 Work group report Something new in the air: Paying for community-based environmental approaches to asthma prevention and control February 2017 Work group report Use of antihistamines in patients with asthma November 2002 Position statement Climate Change Statement name Published Statement type Climate change and our environment: the effect on respiratory and allergic disease March 2013 Work group report Drug Allergy Statement name Published Statement type Cephalosporin administration to patients with a history of penicillin allergy May 2009 Work group report Risk of severe allergic reactions from the use of potassium iodide for radiation emergencies November 2004 Position statement Eosinophilic Esophagitis (EoE) Statement name Published Statement type Dietary Therapy and Nutrition Management of Eosinophilic Esophagitis: A Work Group Report of the American Academy of Allergy, Asthma, and Immunology March 2017 Work group report Food Allergy Statement name Published Statement type AAAAI support of the EACCI paper on IgG4 May 2010 Paper Allergist-reported trends in the practice of food allergen oral immunotherapy January/February 2015 Work group report Conducting an Oral Food Challenge: An Update to the 2009 Adverse Reactions to Foods Committee January 2020 Work Group Report Conducting an oral food challenge to peanut in an infant March/April 2017 Work group report Current approach to the diagnosis and management of adverse reactions to foods October 2003 Work group report Food allergy guidance in the United States military: A work group report from the American Academy of Allergy, Asthma & Immunology’s Military Allergy and Immunology Assembly June 2018 Work group report Food Allergy in Restaurants January 2020 Work Group Report The Allergist’s Role in Anaphylaxis and Food Allergy Management in the School and Childcare Setting November 2017 Work group report Food Protein–Induced Enterocolitis Syndrome (FPIES) Statement name Published Statement type International consensus guidelines for the diagnosis and management of food protein–induced enterocolitis syndrome: Executive summary—Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology April 2017 Position Statement General Health/Public Health Statement name Published Statement type Access to care November 2004 Reaffirmed 2009 Position statement Allergy pay for performance August 2007 Position statement Insurance coverage for H-1 antihistamines: implications for quality health care and public safety November 2002 Position statement Over-the-counter antihistamines December 2002 Position statement Quality Measures and Their Importance to Allergy/Immunology - The Journal of Allergy and Clinical Immunology: In Practice January 2015 Commitee Report Tobacco and smoking February 2004 Position statement Immunology Statement name Published Statement type Appropriate use of intravenously administered immunoglobulin (IVIG) August 2005 Position statement Idiopathic environmental intolerances January 1999 Position statement Update on the use of immunoglobulin in human disease: A review of evidence March 2017 Work group report Immunotherapy Statement name Published Statement type Adrenergic blockers, allergen immunotherapy and skin testing November 2002 Position statement Wait period after allergen immunotherapy and skin testing November 2002 Position statement Integrative Health Interview Statement name Published Statement type Conducting an Integrative Health Interview March 2018 Work group report Mast Cell Disorders Statement name Published Statement type AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management October 2019 Work group report Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology March 2019 Work group report Outdoor Allergies Statement name Published Statement type Finding Relief in Your Backyard: A Guide to Picking Less Allergenic Plants November/December 2018 Work group report Penicillin Allergy Statement name Published Statement type Penicillin allergy testing should be performed routinely in patients with self-reported penicillin allergy February 2017 Position Statement Primary Immunodeficiency Statement name Published Statement type Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: Aworking group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology January 2020 Work Group Report Use and interpretation of diagnostic vaccination in primary immunodeficiency September 2012 Work group report Skin Allergy Statement name Published Statement type Management of difficult-to-treat atopic dermatitis March 2013 Work group report Topical calcineurin inhibitor task force report February 2006 Work group report Stinging Insect Allergy Statement name Published Statement type AAAAI/ACAAI joint venom extract shortage task force report February 2017 Work group report Insect sting allergy with negative venom skin test responses May 2001 Work group report Telemedicine Statement name Published Statement type COVID-19: Unmasking Telemedicine July 2020 Work Group Report Wellness Statement name Published Statement type Physician Wellness in Allergy and Immunology April 2020 Work Group Report Share this page: